Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
about
Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT miceSubstitution of the Rev-response element in an HIV-1-based gene delivery system with that of SIVmac239 allows efficient delivery of Rev M10 into T-lymphocytes.Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactionsThe Vpr protein from HIV-1: distinct roles along the viral life cycleThe histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcriptionRole of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells.The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infectionHIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasomeHuman immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription.Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathwayC-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in transHIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activatorHIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infectionHIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomesAPOBEC3G contributes to HIV-1 variation through sublethal mutagenesisHuman immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2AHuman immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repairHIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activationDDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrestHuman immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrestHuman immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustardLentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycleMaedi-visna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat proteinMutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 VprIdentification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virionAnalysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiaeThe role of cullin 5-containing ubiquitin ligasesActivation of the DNA Damage Response by RNA VirusesTranslational Control of the HIV Unspliced Genomic RNAHIV-1 and M-PMV RNA Nuclear Export Elements Program Viral Genomes for Distinct Cytoplasmic Trafficking Behaviors.The regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapseA Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral EntryThe Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and InfectionMutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entryIdentification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C VirusHow SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest.Small heat shock protein suppression of Vpr-induced cytoskeletal defects in budding yeast.Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
P2860
Q21133769-E1F0DEDD-5505-40CE-BE9B-A6BEFF147633Q21245027-1C7DEF66-C4FC-46D2-BD0D-2F20F8E4859EQ21245114-7CC5ED08-B954-41B4-8B06-8C4C6AA5E12BQ21245211-6F78DC31-8073-4AAC-BF15-80768B0AAFB9Q24307870-6AC35014-2CC1-4FB8-AD5D-3892CE833D10Q24317608-D69E3BD2-2D07-4F5E-9583-95367F93D881Q24318267-D43B037E-AF88-4CA2-A6B6-37DA208CE6ADQ24338212-20F60BA0-93D7-44F8-9954-776F49D7462FQ24523263-732E0120-A7AA-4E49-A2A6-02410B2852D7Q24523667-AD04F148-7299-4547-B8AD-61D640A88889Q24530134-9E6E7608-107E-4802-9AEA-16F3707B8BCEQ24537682-15D60940-1E27-4069-A951-E11897C8AAECQ24569559-A6CE3928-A9A3-4866-9A04-73BCC24A270CQ24608690-15707EB4-A61F-4A15-8231-A0EF8CAFE98FQ24610197-D6862C23-A5F2-4FD9-A04F-E8C1C5E69A6EQ24618320-FAC4E615-C627-43C7-AA12-EBEA9788930CQ24630574-61F37C86-6601-4C1C-8A64-5F03EB58A10FQ24653439-6B2FC5C2-706F-41DC-A6A3-326DB3BAC283Q24669980-F152E774-6693-4991-B49D-D3C4986BB95BQ24671784-D3D9DB74-46BA-4274-8CA1-AE1B13E469F6Q24672382-CE3E29EF-184A-4C19-87FB-E3E549DAC449Q24673660-1A81A971-7C76-4528-BEDB-2F689EF351E4Q24674793-5FEB27C1-F6EF-4A16-A628-E2B31E2164DEQ24680705-04CE1DCB-07A6-42F1-B236-4C1E52330789Q24683315-7CC5AA3E-3DC7-4F92-8C7F-D4A1F0EEDED4Q24684633-CEDECA1C-614D-4AC4-91B1-33A64CEF1B1FQ24797248-9D11AEFC-E174-4C35-A812-38DBE37952F9Q24804945-6E9B3662-A45D-484C-8A80-A28612B26F45Q26749274-1B6BDC74-E1E3-4FD3-862F-6DBC15F471CCQ26769967-3A6B52A0-CDD7-4242-8526-D7822D4C7645Q26801493-64A63E2B-DC2F-4387-A5D0-500B304D864EQ27314862-8FE2C91B-3DDA-4C0A-A8B8-88BC91C696AAQ27349077-D1267010-B8FF-4212-8A29-30942AB0870FQ27477463-8E852428-87DF-4B1F-851C-B51A161AFF29Q27488990-55F0F163-51FB-4210-B096-26473A3764D5Q27489898-6F6BC7F0-CCA3-4BB0-B32E-2CA82B546F37Q27490467-FC1E4FA3-A68D-4211-9FC4-19862A5F46B2Q27693229-8FD70584-5D90-447C-A32F-3B8B143E3024Q27934278-D1602530-7240-4EAA-9BCD-D4E1B19D3759Q28216909-564DE902-1035-468F-9C1E-AB7D66F2FAA4
P2860
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@ast
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@en
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@nl
type
label
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@ast
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@en
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@nl
prefLabel
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@ast
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@en
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@nl
P2093
P2860
P3181
P1433
P1476
Human immunodeficiency virus t ...... by inhibiting p34cdc2 activity
@en
P2093
P2860
P304
P3181
P407
P577
1995-11-01T00:00:00Z